| scholarly article | Q13442814 |
| P2093 | author name string | Hisanobu Ogata | |
| Jacquelyn J Maher | |||
| Scott M Turner | |||
| Carine Beysen | |||
| James P Grenert | |||
| Jim S Yan | |||
| Michael K Pickens | |||
| Raymond K Ng | |||
| P2860 | cites work | Effects of a low-fat, high-carbohydrate diet on VLDL-triglyceride assembly, production, and clearance | Q24563129 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
| The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis | Q28238742 | ||
| The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes | Q28296454 | ||
| Effects of pregnancy and ovarian steroids on fatty acid synthesis and uptake in Syrian hamsters | Q28334776 | ||
| Regulation of hepatic lipogenesis by the transcription factor XBP1 | Q28507784 | ||
| A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver | Q28583240 | ||
| Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease | Q29619334 | ||
| Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations | Q33654282 | ||
| Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat | Q33901239 | ||
| Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice | Q33954022 | ||
| Measurement of de novo hepatic lipogenesis in humans using stable isotopes | Q34190285 | ||
| CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis | Q34432561 | ||
| The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity | Q34512981 | ||
| Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream | Q34683632 | ||
| Triglyceride accumulation protects against fatty acid-induced lipotoxicity | Q34866329 | ||
| Regulation of stearoyl-CoA desaturases and role in metabolism | Q35599793 | ||
| Glucose as a regulator of eukaryotic gene transcription | Q36306015 | ||
| Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice | Q36479005 | ||
| Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis | Q36557194 | ||
| Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet | Q36558384 | ||
| The effects of glyceride structure on absorption and metabolism | Q37300770 | ||
| Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin | Q38338847 | ||
| Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes | Q40064603 | ||
| Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis | Q40108223 | ||
| Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells | Q40313352 | ||
| Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice | Q40612270 | ||
| Tracing lipogenesis in humans using deuterated water | Q41203751 | ||
| ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver | Q42128898 | ||
| Measurement of TG synthesis and turnover in vivo by 2H2O incorporation into the glycerol moiety and application of MIDA. | Q44489677 | ||
| Central role of PPARalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice | Q44493750 | ||
| Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury | Q44680230 | ||
| The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance | Q44691209 | ||
| A choline-deficient diet in mice inhibits neither the CDP-choline pathway for phosphatidylcholine synthesis in hepatocytes nor apolipoprotein B secretion | Q44801438 | ||
| Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. | Q46019598 | ||
| In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis | Q46103108 | ||
| Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulinemic subjects consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets | Q46121875 | ||
| Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. | Q46254429 | ||
| Steatohepatitis induced by intragastric overfeeding in mice | Q46320547 | ||
| Lipid metabolism and antioxidant status in sucrose vs. potato-fed rats | Q46609451 | ||
| Use of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans | Q46666080 | ||
| Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways | Q46749883 | ||
| JNK1 but not JNK2 promotes the development of steatohepatitis in mice | Q46865809 | ||
| Oxidative stress markers in preovulatory follicular fluid in humans | Q48917494 | ||
| Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: effects on blood lipids, factor VII coagulant activity, and fibrinogen. | Q51555382 | ||
| Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects. | Q51557334 | ||
| Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. | Q53555710 | ||
| Dietary Sucrose but not Starch Promotes Protein-Induced Differences in Rates of VLDL Secretion and Plasma Lipid Concentrations in Rats | Q68186071 | ||
| The phosphatidylethanolamine N-methyltransferase pathway is quantitatively not essential for biliary phosphatidylcholine secretion | Q80535952 | ||
| Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis | Q82677113 | ||
| P433 | issue | 10 | |
| P921 | main subject | steatohepatitis | Q2335423 |
| P304 | page(s) | 2072-2082 | |
| P577 | publication date | 2009-03-17 | |
| P1433 | published in | Journal of Lipid Research | Q6295449 |
| P1476 | title | Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis | |
| P478 | volume | 50 |
| Q35294536 | Ablation of Foxl1-Cre-labeled hepatic progenitor cells and their descendants impairs recovery of mice from liver injury |
| Q90324639 | Analysis of the dietary factors associated with suspected pediatric nonalcoholic fatty liver disease and potential liver fibrosis: Korean National Health and Nutrition Examination Survey 2014-2017 |
| Q42923984 | Are Ethanol and Fructose Similar? |
| Q90478758 | Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis |
| Q41617791 | CD18 deficiency improves liver injury in the MCD model of steatohepatitis. |
| Q38415993 | Choline requirements of White Pekin ducks from hatch to 21 days of age. |
| Q59789588 | Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD |
| Q33623803 | Detection of driver metabolites in the human liver metabolic network using structural controllability analysis. |
| Q92826678 | Dietary Fructose and the Metabolic Syndrome |
| Q41421372 | Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet |
| Q35672132 | Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis |
| Q33579420 | Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice. |
| Q40689856 | Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome |
| Q34622930 | Fructose: Metabolic, Hedonic, and Societal Parallels with Ethanol |
| Q30428239 | Fructose: it's "alcohol without the buzz". |
| Q24634120 | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation |
| Q37777696 | Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites |
| Q102220441 | Hepatocyte-specific deletion of XBP1 sensitizes mice to liver injury through hyperactivation of IRE1α |
| Q41856930 | High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase |
| Q30453231 | Inflammation in nonalcoholic steatohepatitis |
| Q27330629 | Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible? |
| Q92354069 | Isocaloric Fructose Restriction Reduces Serum d-Lactate Concentration in Children With Obesity and Metabolic Syndrome |
| Q38576287 | Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury |
| Q33840334 | Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death |
| Q37484376 | Lipid metabolism, oxidative stress and cell death are regulated by PKC delta in a dietary model of nonalcoholic steatohepatitis |
| Q27007233 | Low-carbohydrate ketogenic diets, glucose homeostasis, and nonalcoholic fatty liver disease |
| Q64229141 | Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver |
| Q36323842 | Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy |
| Q46263811 | Modeling fatty liver disease in animals: Is there an optimal approach, and is the effort worthwhile? |
| Q34854719 | Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet |
| Q35931190 | NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications. |
| Q30277911 | NKp46(+) natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice |
| Q46228637 | NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice. |
| Q37815214 | New insights from rodent models of fatty liver disease |
| Q39445103 | Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease |
| Q89900938 | Oral dextrose reduced procedural pain without altering cellular ATP metabolism in preterm neonates: a prospective randomized trial |
| Q41468088 | PKC{delta} is activated in a dietary model of steatohepatitis and regulates endoplasmic reticulum stress and cell death. |
| Q54408005 | PREP1 deficiency downregulates hepatic lipogenesis and attenuates steatohepatitis in mice. |
| Q51068461 | Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis. |
| Q33863614 | Recent progress in understanding protein and lipid factors affecting hepatic VLDL assembly and secretion |
| Q34979884 | Role of choline deficiency in the Fatty liver phenotype of mice fed a low protein, very low carbohydrate ketogenic diet |
| Q33802995 | Specific Macronutrients Exert Unique Influences on the Adipose-Liver Axis to Promote Hepatic Steatosis in Mice. |
| Q34997512 | Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery |
| Q42391560 | Stress Signaling in the Methionine-Choline–Deficient Model of Murine Fatty Liver Disease |
| Q96137718 | Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models |
| Q50473358 | The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. |
| Q37724585 | The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome |
| Q37973444 | Therapeutic potential of green tea in nonalcoholic fatty liver disease. |
| Q34255878 | Toward a unifying hypothesis of metabolic syndrome. |
| Q28385817 | What is metabolic syndrome, and why are children getting it? |
Search more.